Is 1mg of Wegovy a Lot, or Just Part of the Journey?

The myth: 1mg sounds small, so it probably isn't doing much

This is the most common misunderstanding people raise when they reach this stage. They've read that the maintenance dose is 2.4mg, done the arithmetic, and concluded that 1mg is barely a quarter of the way there. That reading misses the point of how semaglutide works in practice.

Wegovy's titration schedule isn't a dial you turn up until you find the setting that works. Each step (including 1mg) has a real pharmacological effect; the stepwise increase is primarily about tolerability, not potency. The GLP-1 receptor agonist mechanism slows gastric emptying and reduces appetite signals, and ramping too quickly causes avoidable nausea and vomiting. Starting low and moving gradually is how the medicine is designed to be used, as set out in the NHS patient information for semaglutide.

Some people do notice meaningful changes in appetite and scale weight by the time they reach 1mg. Others notice less, and that is equally normal, the therapeutic effect builds across the full schedule. Neither experience tells you whether the medicine will ultimately work for you; only the maintenance phase makes that picture clear. Questions about your own response are worth raising with your prescriber, not guessing from dose numbers alone.

Where 1mg sits in the full Wegovy dose schedule

The licensed titration for the Wegovy injection runs: 0.25mg for the first four weeks, 0.5mg for the next four, then 1mg, then 1.7mg, and finally the 2.4mg maintenance dose. That puts 1mg at the exact midpoint, week nine to twelve or so for most people, assuming no pauses. A broader look at the Wegovy dose schedule maps out what each stage typically looks like.

One thing worth knowing: the schedule isn't always strictly linear. If side effects are significant at a given step, a prescriber may keep you at that dose for longer before moving up, or in some cases step back temporarily. That is a clinical decision. The published schedule is a guide, not a countdown timer, and the right pace is personal. If you're wondering whether 1mg feels like enough compared with what others experience, the question of how strong 1mg really is gets into the clinical detail behind that.

The STEP 1 trial (the pivotal 68-week semaglutide study published in the New England Journal of Medicine) showed an average body-weight reduction of around 15% in the treatment group. That outcome was achieved at the 2.4mg maintenance dose sustained over the full trial period, not at any intermediate step. It takes time, and 1mg is part of that time.

Side effects at the 1mg stage, what typically happens

The most commonly reported side effects at any point on the Wegovy titration are gastrointestinal: nausea, loose stools, constipation, indigestion, and burping. These tend to be most noticeable in the first week or two after a dose increase, including the step up to 1mg, and settle for many people as the weeks pass.

If you're moving from 0.5mg to 1mg and noticing more nausea than before, that is the expected pattern rather than a sign the medicine disagrees with you. Eating smaller portions, avoiding rich or fatty food, and staying hydrated all help. If symptoms are severe or persistent, speak to your prescriber, never assume you simply have to push through. Serious but uncommon symptoms to be aware of at any dose include severe stomach pain that radiates to the back, which should prompt urgent medical attention given what is known about acute pancreatitis and GLP-1 medicines.

Side effects worth reporting (whether mild or unexpected) can be logged via the MHRA's Yellow Card scheme, which is how the regulator builds its ongoing safety picture for Black Triangle medicines like Wegovy. If you have broader questions about the titration experience, our FAQs cover many of the things people ask at this stage.

What to expect as you move beyond 1mg

The next step after 1mg is 1.7mg, typically after another four weeks, and then 2.4mg. For most people on the programme, weight loss tends to become more pronounced as doses increase, not because lower doses did nothing, but because the appetite-reduction effect is dose-related and the higher maintenance dose is where the majority of the clinical benefit studied in trials was observed. If you have questions about how those later steps feel in practice, there is specific guidance on whether 1.7mg of Wegovy is a lot and on whether 2.4mg of Wegovy is a lot to help put both doses into context.

There's a separate question about what happens if weight loss slows or stalls once you do reach 2.4mg. That is a different situation from being at 1mg mid-titration, it is covered in more detail for anyone finding that Wegovy at 2.4mg seems to have stopped working.

If you are thinking about costs as your treatment progresses, understanding the Wegovy price landscape in the UK is useful context, prices vary between providers, and the full clinical picture matters as much as the headline figure. Wegovy is a prescription-only medicine; clinical suitability is assessed before every stage. Check your eligibility and speak to our prescribers to understand what the right path looks like for you by starting a free consultation at our treatment page. A real clinician reviews your answers the same day, not software, not a queue.